Lipocine Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Total Revenue - 7,710 -
Cost of Revenue - - -
Gross Profit - 7,710 -
Operating Expenses
Research and Development 5,123 2,281 -
Sales, General and Admin. 4,549 1,551 5
Non-Recurring Items 1,012 - -
Other - - -
Operating Income (10,684) 3,877 (5)
Income From Continuing Operations
Add'l Income/Expense Items 38 10 -
Earnings Before Interest and Tax (10,645) 3,888 (5)
Interest Expense - - -
Earnings Before Tax (10,645) 3,888 (5)
Income Tax (55) 1 -
Minority Interest - - -
Equity Earnings Unconsolidated Subsidiary - - -
Net Income Cont. Operations (10,590) 3,887 (5)
Non Recurring Events
Discontinued Operations - - -
Extraordinary Items - - -
Effect of Accounting Changes - - -
Other Items - - -
Net Income (10,590) 3,887 (5)
Preferred Stock and Other Adjustments - - -
Net Income Applicable to Common Shareholders (10,590) 3,887 (5)